These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30745235)

  • 21. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for cystic fibrosis-related diabetes: a systematic review.
    Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
    Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semaglutide in Cystic Fibrosis-Related Diabetes.
    Gnanapragasam H; Mustafa N; Bierbrauer M; Andrea Providence T; Dandona P
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32232400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
    Tommerdahl KL; Brinton JT; Vigers T; Nadeau KJ; Zeitler PS; Chan CL
    Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Screening and management of glucose metabolism disorders in cystic fibrosis patients. Practices survey in 4 French reference centers].
    Haesebaert J; Bourdy S; Perceval M; Chabloz C; Nove-Josserand R; Reix P; Llerena C; Wion N; Touzet S
    Arch Pediatr; 2009 Nov; 16(11):1435-42. PubMed ID: 19811898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus.
    Ballmann M; Hubert D; Assael BM; Kronfeld K; Honer M; Holl RW;
    BMC Pediatr; 2014 Mar; 14():70. PubMed ID: 24620855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving screening for diabetes in cystic fibrosis.
    Abdulhamid I; Guglani L; Bouren J; Moltz KC
    Int J Health Care Qual Assur; 2015; 28(5):441-51. PubMed ID: 26020427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory testing in diabetes mellitus.
    Leroux M
    Adv Exp Med Biol; 2001; 498():359-66. PubMed ID: 11900391
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperglycemia and death in cystic fibrosis-related diabetes.
    Adler AI; Shine B; Haworth C; Leelarathna L; Bilton D
    Diabetes Care; 2011 Jul; 34(7):1577-8. PubMed ID: 21593303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving screening for cystic fibrosis-related diabetes at a pediatric cystic fibrosis program.
    Kern AS; Prestridge AL
    Pediatrics; 2013 Aug; 132(2):e512-8. PubMed ID: 23821699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis-Related Diabetes with strict glycaemic control is not associated with frequent intravenous antibiotics use for pulmonary infections.
    Belle-van Meerkerk G; de Valk HW; Stam-Slob MC; Teding van Berkhout F; Zanen P; van de Graaf EA
    Diabetes Res Clin Pract; 2016 Jun; 116():230-6. PubMed ID: 27321340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories.
    Sacks DB
    Clin Chem; 2009 Sep; 55(9):1612-4. PubMed ID: 19589842
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical updates in cystic fibrosis-related diabetes.
    Brennan AL; Beynon J
    Semin Respir Crit Care Med; 2015 Apr; 36(2):236-50. PubMed ID: 25826591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic control and FEV
    Okoniewski W; Hughan KS; Weiner GA; Weiner DJ; Forno E
    J Cyst Fibros; 2020 May; 19(3):460-465. PubMed ID: 31980357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
    Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
    PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment of diabetes in adult patients with cystic fibrosis].
    Robert JJ; Mosnier-Pudar H
    Rev Mal Respir; 2000 Aug; 17(3 Pt 2):798-801. PubMed ID: 11076389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated haemoglobin determinations.
    De Schepper J; Dab I; Derde MP; Loeb H
    Eur J Pediatr; 1991 Apr; 150(6):403-6. PubMed ID: 2040347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.